QIAGEN N.V. to Report Third Quarter 2014 Results and Hold Webcast
VENLO, The Netherlands, October 10, 2014 /PRNewswire/ --
QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) today reconfirmed plans to release its report on results for the third quarter 2014 on Wednesday, October 29, at 21:00 Central European Time (CET) / 16:00 Eastern Time (ET).
On the same day, a conference call is planned at 22:00 Central European Time (CET) / 17:00 Eastern Time (ET) that will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer.
Conference Call & Webcast Details
The conference call will begin at 22:00 CET / 17:00 ET on October 29, 2014. Interested parties may listen to the call by dialing:
+1-855-272-3518 (US), +44(0)203-059-5869 (UK), +49(0)69-566-036-000 (Germany)
The webcast will be accessible at http://www.qiagen.com/About-Us/Investors/Events-and-Presentations/Conference-Calls.
A replay of the conference call will be available through November 5, 2014, by dialing:
+1-866-268-1947 (US), +44(0)121-260-4861, +49(0)69-710-488-70 (passcode: 359145#).
Contact: [email protected]
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of June 30, 2014, QIAGEN employed approximately 4,200 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.
SOURCE QIAGEN N.V.
Share this article